Results 201 to 210 of about 10,271 (300)

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher   +12 more
wiley   +1 more source

A cross-consortium, stakeholder-driven model for implementing a modern electronic data capture and submission system across the Alzheimer's Disease Research Centers Program. [PDF]

open access: yesAlzheimers Dement
Biber S   +16 more
europepmc   +1 more source

Comparative performance of risk prediction indices for mortality or readmission following heart failure hospitalization

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1227-1236, April 2025.
Comparative performance of 7 risk prediction indices in patients hospitalized for heart failure. In this cohort of 1206 patients, the LENT index offered the greatest discrimination, calibration, and overall accuracy in predicting 30‐day composite all‐cause mortality or readmission following hospitalization for heart failure.
Tauben Averbuch   +8 more
wiley   +1 more source

myAURA: a personalized health library for epilepsy management via knowledge graph sparsification and visualization. [PDF]

open access: yesJ Am Med Inform Assoc
Correia RB   +14 more
europepmc   +1 more source

Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1479-1484, April 2025.
Abstract Aims The VICTORIA trial demonstrated a significant reduction in the primary composite outcome of heart failure (HF) hospitalization or cardiovascular death with vericiguat relative to placebo in high‐risk HF. This study aimed to contextualize treatment effects of vericiguat in populations with varying risk profiles simulated from the PARADIGM ...
Veraprapas Kittipibul   +13 more
wiley   +1 more source

A standardized personality lexicon for enhancing personalized human-machine interaction. [PDF]

open access: yesSci Data
Jin T   +9 more
europepmc   +1 more source

An Experience‐Sampling Study on the Frequency and Diversity of Positive and Negative Affective States

open access: yesEuropean Journal of Social Psychology, EarlyView.
ABSTRACT Ecological models explain social phenomena by assuming specific properties of the world an individual lives in. The evaluative information ecology model (Unkelbach et al. 2019) assumes two such properties: Positive information is more frequent (i.e., positivity prevalence), but negative information is more diverse (i.e., negativity diversity).
Anne I. Weitzel, Christian Unkelbach
wiley   +1 more source

The EU's Strategy for Sustainability: A Landmark Turn With the European Green Deal?

open access: yesEuropean Policy Analysis, EarlyView.
ABSTRACT While the European Green Deal (EGD) has been widely recognized as a milestone in the EU's sustainability strategy, scholars disagree on the nature of the policy change it represents. Critics highlight its limited social and environmental ambitions, despite its portrayal as a “man on the moon” moment.
Ekaterina Domorenok, Franco Gatti
wiley   +1 more source

SmartCrop: knowledge base of molecular genetic mechanisms of rice and wheat adaptation to stress factors. [PDF]

open access: yesVavilovskii Zhurnal Genet Selektsii
Demenkov PS   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy